Tolterodine Tablets

These tablets are indicated for urinary urgency and formulated to mitigate bladder contractions to relieve urinary frequency symptoms.

Strengths: 1 · 2mg

Medicine details

Alternative names

Detrusitol

Therapeutic class

Antimuscarinic

Pharmacological class

Muscarinic receptor antagonist

Minor side effects

dry mouth; dyspepsia; headache; fatigue

Moderate side effects

constipation; abdominal pain; blurred vision; dizziness

Dosage forms

Tablet; Prolonged-release capsule, hard

Administration route

Oral use

Prescription status

POM

Manufacturer

Pfizer

Onset Time

1–2 hours

Duration

24 hours

Storage instructions

Store at room temperature in a dry place.

Drug interactions

other antimuscarinics; CYP3A4 inhibitors

Age restrictions

Generally not indicated for children.

Pregnancy and breastfeeding

Pregnancy: Use only if necessary. Breastfeeding: Not recommended.

Contraindications

urinary retention; uncontrolled angle-closure glaucoma; myasthenia gravis; severe ulcerative colitis

Precautions and warnings

use with caution in autonomic neuropathy; use with caution in renal impairment; may cause drowsiness

Serious side effects

urinary retention — requires immediate medical attention; angioedema — requires immediate medical attention

Patient summary

These tablets are indicated for urinary urgency and formulated to mitigate bladder contractions to relieve urinary frequency symptoms.

Mechanism of action

Tolterodine acts as a competitive antagonist at muscarinic receptors, relaxing detrusor smooth muscle to increase bladder capacity and reduce involuntary contractions.

Tolterodine Tablets

These tablets are indicated for urinary urgency and formulated to mitigate bladder contractions to relieve urinary frequency symptoms.

Editorial Notes

  • Active ingredient(s): Tolterodine
  • Listed indication(s): Urinary Frequency, Urinary Urgency, Urinary Incontinence

Usually available as

  • 60 tablets - 1 mg1329-1-mg-15939
  • 60 tablets - 2 mg1329-2-mg-15934